<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000140.v1.p1" parentStudy="phs000140.v1.p1" createDate="2008-06-27" modDate="2010-11-24">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Donald Bowden, PhD</td><td>Center for Human Genomics, Center for Diabetes Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA</td></tr>
		<tr><td>Funding Source</td><td>R01 DK53591</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>R01 DK066358</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source for Genotyping</td><td>HHSN268200782096C. NIH contract &quot;High throughput genotyping for studying the genetic contributions to human disease&quot;</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans</StudyNameEntrez>
	<StudyNameReportPage>A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Over 2.8 million African Americans have type 2 diabetes mellitus (T2DM).  This represents approximately 13% of the African American  	population and a significant proportion of the 21 million Americans living with diabetes. On average, an African American individual  	is twice as likely to have T2DM as a European American peer. Our research group has been actively involved in the study of African  	American diabetes genetics for over 15 years. We hypothesize that genes contributing to the development of T2DM in African Americans  	exist and can be located using modern molecular genetic methods. With the exception of TCF7L2(Transcription factor 7-like 2) evidence  	to date suggests variants that contribute T2DM risk in European-derived populations are not significant contributors to African  	American T2DM risk. We have performed a SNP-based Whole Genome Association (WGA) analysis on the Affymetrix 6.0 in a  	case control population of over 1000 African American T2DM cases and over 1000 non-diabetic controls. The DNAs have been  	collected from participants using uniform criteria from North Carolina and neighboring states. Genotype data will  	be subjected to extensive genetic analysis with the goal of defining a priority list of SNPs for genotyping in independent  	populations for confirmation and further detailed analysis.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Cases</b>: For this study we propose to focus on the unrelated cases and controls in our collection. Consenting  		self-identified African Americans, age 35 or older, born in North Carolina, South Carolina, Georgia, Virginia, or Tennessee,  		were eligible for participation. Recruiting was performed at clinical facilities, health fairs, church participation, and  		through public advertising using a uniform ascertainment. T2DM was diagnosed in patients who received oral hypoglycemic  		agents or dietary therapy without insulin for at least one year after initial diagnosis and in whom initial diagnosis  		of diabetes mellitus occurred after age 35.  Patients with a history of diabetic ketoacidosis or who developed  		diabetes mellitus prior to age 25 and received continuous insulin therapy since diagnosis, were presumed to have type 1  		diabetes and were ineligible.  For the 1000 cases proposed for the WGA analysis, we wish to use DNAs from cases with  		T2DM and DM-ESRD (Diabetes Mellitus - End Stage Renal Disease), which make up a majority of our collection. The  		great advantage of this approach is that these cases are clearly long term diabetes affected individuals and with the WGA of  		T2DM we will also get a WGA of DM-ESRD. Importantly, as outlined below, we have the capability to differentiate between  		genes which contribute solely to T2DM and solely DM-ESRD through our other collections and collaborations. There is no  		extant literature that suggests that there are any population-based differences between subjects with T2DM (without ESRD)  		and subjects with T2DM and DM-ESRD. If there are unperceived differences we would note that subjects with DM-ESRD has one  		of the most devastating complications of diabetes and are thus of high importance to study.</p>  		<p><b>Controls</b>: Control samples have been recruited from health fairs, church participation, and public advertising.  		The great majority of the control subjects have fasting plasma glucose (FPG) measures and renal function analysis  		and are designated (diabetes) controls if they have FPG &#8804; 100 mg/dL consistent with current American Diabetes  		Association (ADA) definition and no evidence of microalbuminuria. It is noteworthy that the mean BMI of cases  		and controls are similar and that the mean age of examination for the controls is 8.7 years later than the  		mean age of diagnosis for the cases.</p>  		<p><b>Exclusions</b>: Inability to provide informed consent.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="7648217"/>
		</Publication>
		<Publication>
			<Pubmed pmid="8989734"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9067916"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9524057"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9535413"/>
		</Publication>
		<Publication>
			<Pubmed pmid="10023641"/>
		</Publication>
		<Publication>
			<Pubmed pmid="10642288"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11031105"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11071967"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11849458"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11919401"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12200799"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12631337"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12830465"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12837270"/>
		</Publication>
		<Publication>
			<Pubmed pmid="14988270"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15073382"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15458446"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15701670"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15872076"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16138910"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16140553"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16285158"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16735643"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17205963"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17327435"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17601994"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17618154"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17942768"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18184924"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18305958"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18443202"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18560894"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18580054"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18654799"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Diabetes Mellitus, Type 2"/>
		<Disease vocab_source="MESH" vocab_term="Diabetic Nephropathies"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Donald Bowden, PhD</AttName>
			<Institution>Center for Human Genomics, Center for Diabetes Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01 DK53591</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01 DK066358</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source for Genotyping">
			<AttName>HHSN268200782096C. NIH contract &quot;High throughput genotyping for studying the genetic contributions to human disease&quot;</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>The development of this study reflects a 15 year commitment to the study of the genetics of type 2 diabetes and  		complications of diabetes in the African American population. Multiple studies in the African American population have  		contributed to creating a sample collection appropriate for the initial GWAS and subsequent follow-up replication studies.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects."/>
		<ConsentGroup groupNum="1" shortName="T2D" longName="T2D and complications"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIDDK</DacName>
      <DacFullName>NIDDK Central Repository GWAS Data Access Committee</DacFullName>
      <DacEmail>niddk-dac@mail.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-480-3510</DacFax>
      <DacUrl>http://www3.niddk.nih.gov/researchprograms/repositories/FAQ.shtml</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000140.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>3</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000140.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000140.v1.p1" FileName="ModeNIDDKdbGaPlDUC_2010April7_FINAL.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>T2D and complications</ConsentName>
        <ConsentAbbrev>T2D</ConsentAbbrev>
        <UseLimitation>Type 2 diabetes and its complications</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd001164.1" type="questionnaire" createDate="2008-06-27" modDate="2009-10-08" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd001164.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000140.v1.p1&amp;phd=1164">
      <OrigName>BG00_427DMSQuestionnaire.pdf</OrigName>
      <DisplayName>Participant Questionnaire: &lt;underline&gt;Cases&lt;/underline&gt;</DisplayName>
      <Description>Participant Questionnaire: &lt;underline&gt;Cases&lt;/underline&gt;</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd001165.1" type="questionnaire" createDate="2008-06-27" modDate="2009-10-08" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd001165.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000140.v1.p1&amp;phd=1165">
      <OrigName>BG00_427RGFQuestionnaire.pdf</OrigName>
      <DisplayName>Participant Questionnaire: &lt;underline&gt;Controls&lt;/underline&gt;</DisplayName>
      <Description>Participant Questionnaire: &lt;underline&gt;Controls&lt;/underline&gt;</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>

  <Annotations>
    <DocumentPart phd="phd001164.1" sectionId="V13">
      <phvList>
        <phvRef variableId="66339"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V14">
      <phvList>
        <phvRef variableId="66338"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V16">
      <phvList>
        <phvRef variableId="66340"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V3">
      <phvList>
        <phvRef variableId="66337"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V42">
      <phvList>
        <phvRef variableId="66341"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V50">
      <phvList>
        <phvRef variableId="66343"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V58">
      <phvList>
        <phvRef variableId="66349"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V63">
      <phvList>
        <phvRef variableId="66345"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V64">
      <phvList>
        <phvRef variableId="66347"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001164.1" sectionId="V65">
      <phvList>
        <phvRef variableId="66344"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001165.1" sectionId="V15">
      <phvList>
        <phvRef variableId="66353"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001165.1" sectionId="V16">
      <phvList>
        <phvRef variableId="66352"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001165.1" sectionId="V18">
      <phvList>
        <phvRef variableId="66354"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001165.1" sectionId="V44">
      <phvList>
        <phvRef variableId="66355"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001165.1" sectionId="V47">
      <phvList>
        <phvRef variableId="66358"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd001165.1" sectionId="V5">
      <phvList>
        <phvRef variableId="66351"/>
      </phvList>
    </DocumentPart>
  </Annotations>



</Study>

</Studies>

</GaPExchange>
